SPOTLIGHT -
Key Takeaways on Evolving Bladder Cancer Treatment Landscape
The expert panel concludes its discussion by providing key takeaways on the evolving bladder cancer treatment landscape following ESMO 2023.
Approach to Collaborative Care in Bladder Cancer
The panel discusses the Large Urology Group Practice Association and provides insights on collaborative care approaches in bladder cancer.
Enfortumab Vedotin and the Role of ADCs in Bladder Cancer
Bladder cancer specialists discuss enfortumab vedotin and the role of antibody-drug conjugates in the treatment landscape.
Bladder Cancer: Highlights from ESMO 2023 and Ongoing Developments
The expert panel reviews highlights from ESMO 2023 and discusses ongoing developments in the treatment landscape for bladder cancer.
Bladder Cancer: Treatment Options and Managing Adverse Effects
Comprehensive insights on treatment considerations and managing immunotherapy-related adverse effects for patients with bladder cancer.
Monitoring Patients With NMIBC
The panel discusses strategies for monitoring patients with non–muscle invasive bladder cancer and the potential role of biomarkers.
Treatment Considerations and Role of Trimodal Therapy in Bladder Cancer
Expert perspectives on treatment options available for patients with bladder cancer and the role of trimodal therapy.
Overview of Non–Muscle Invasive Bladder Cancer (NMIBC)
A panel of experts on bladder cancer provide an overview of the stratification, natural history, and treatment of bladder cancer.